These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8051415

  • 1. Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient.
    Takahashi T, Makiguchi Y, Hinoda Y, Kakiuchi H, Nakagawa N, Imai K, Yachi A.
    J Immunol; 1994 Sep 01; 153(5):2102-9. PubMed ID: 8051415
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin.
    Noto H, Takahashi T, Makiguchi Y, Hayashi T, Hinoda Y, Imai K.
    Int Immunol; 1997 May 01; 9(5):791-8. PubMed ID: 9184925
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.
    Jerome KR, Barnd DL, Bendt KM, Boyer CM, Taylor-Papadimitriou J, McKenzie IF, Bast RC, Finn OJ.
    Cancer Res; 1991 Jun 01; 51(11):2908-16. PubMed ID: 1709586
    [Abstract] [Full Text] [Related]

  • 4. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
    Kawaoka T, Oka M, Takashima M, Ueno T, Yamamoto K, Yahara N, Yoshino S, Hazama S.
    Oncol Rep; 2008 Jul 01; 20(1):155-63. PubMed ID: 18575732
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides.
    Ioannides CG, Fisk B, Jerome KR, Irimura T, Wharton JT, Finn OJ.
    J Immunol; 1993 Oct 01; 151(7):3693-703. PubMed ID: 7690810
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.
    Brossart P, Schneider A, Dill P, Schammann T, Grünebach F, Wirths S, Kanz L, Bühring HJ, Brugger W.
    Cancer Res; 2001 Sep 15; 61(18):6846-50. PubMed ID: 11559560
    [Abstract] [Full Text] [Related]

  • 12. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.
    Jerome KR, Domenech N, Finn OJ.
    J Immunol; 1993 Aug 01; 151(3):1654-62. PubMed ID: 8393050
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24.
    Rew SB, Peggs K, Sanjuan I, Pizzey AR, Koishihara Y, Kawai S, Kosaka M, Ozaki S, Chain B, Yong KL.
    Clin Cancer Res; 2005 May 01; 11(9):3377-84. PubMed ID: 15867238
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of MUC1 mucin as an escape mechanism of breast cancer cells from autologous cytotoxic T-lymphocytes.
    Kontani K, Taguchi O, Narita T, Izawa M, Hiraiwa N, Zenita K, Takeuchi T, Murai H, Miura S, Kannagi R.
    Br J Cancer; 2001 May 04; 84(9):1258-64. PubMed ID: 11336479
    [Abstract] [Full Text] [Related]

  • 20. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
    Brossart P, Stuhler G, Flad T, Stevanovic S, Rammensee HG, Kanz L, Brugger W.
    Cancer Res; 1998 Feb 15; 58(4):732-6. PubMed ID: 9485028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.